{"DataElement":{"publicId":"2726095","version":"2","preferredName":"Oral Contrast Agent Administered Type","preferredDefinition":"A response to indicate the type of oral contrast agent used (Positive or Negative) as part of the imaging procedure.","longName":"ORAL_CNTST_AGT_TP","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"5829897","version":"1","preferredName":"Oral Contrast Agent Administered","preferredDefinition":"Of, or relating to, or affecting, or for use in the mouth._Substances administered during imaging procedures that allows delineation of internal structures. Contrast agents appear opaque due to the difference in absorption of X-rays or other electromagnetic waves and surrounding tissue._The act of having given something (e.g., a medication or test).","longName":"2727604v1.0:2233610v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2727604","version":"1","preferredName":"Oral Contrast Agent","preferredDefinition":"Oral; of, or relating to, or affecting, or for use in the mouth.:Substances used in radiography that allow visualization of certain tissues.","longName":"C25311:C390","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oral","conceptCode":"C25311","definition":"Of, or relating to, or affecting, or for use in the mouth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Contrast Agent","conceptCode":"C390","definition":"Substances administered during imaging procedures that allows delineation of internal structures. Contrast agents appear opaque due to the difference in absorption of X-rays or other electromagnetic waves and surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"456DCB90-7076-1522-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-05","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2008-02-05","modifiedBy":"ONEDATA","dateModified":"2008-02-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233610","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D864-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2233241","version":"1","preferredName":"Medical Imaging","preferredDefinition":"Events, people, materials and activities uniquely defined by medical imaging.  ","longName":"MEDICAL IMAGING","context":"CIP","contextVersion":"2.31","origin":"DICOM:Digital Imaging and Communications in Medicine","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F96173D7-A9B4-3CBB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-12","modifiedBy":"SBREXT","dateModified":"2006-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"4FB84405-CC8A-0710-E053-F662850A1080","latestVersionIndicator":"Yes","beginDate":"2017-05-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-05-17","modifiedBy":"KNABLEJ","dateModified":"2017-06-21","changeDescription":"5/17/17 tt New DEC per Rnd 5 finalization task.  Supercedes DEC 2717628.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2717683","version":"1.1","preferredName":"Oral Contrast Agent Type","preferredDefinition":"The introduction of a substance to the mouth or into the gastrointestinal tract by the way of the mouth, usually for systemic action. It is the most common, convenient, and usually the safest and least expensive route of drug administration, but it uses the most complicated pathway to the tissues and bioavailability varies. The disadvantages of method are hepatic first pass metabolism and enzymatic degradation of the drug within the gastrointestinal tract. This prohibits oral administration of certain classes of drugs especially peptides and proteins._Substances administered during imaging procedures that allows delineation of internal structures. Contrast agents appear opaque due to the difference in absorption of X-rays or other electromagnetic waves and surrounding tissue._Something distinguishable as an identifiable class based on common qualities.","longName":"ORAL_CONTRAST_TP","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"0","maxLength":"8","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Negative","valueDescription":"Negative Contrast Agent","ValueMeaning":{"publicId":"2717684","version":"1","preferredName":"Negative Contrast Agent","longName":"2717684","preferredDefinition":"Contrast media that has a lower amplification and intensity than the surrounding tissue making the contrast look less opaque when seen in an x-ray.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negative Contrast Agent","conceptCode":"C71960","definition":"Contrast media that has a lower amplification and intensity than the surrounding tissue making the contrast look less opaque when seen in an x-ray.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"428B61E4-2CDF-1694-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-12-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4FBA87A7-535C-3649-E053-F662850A6B71","beginDate":"2008-02-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-05-17","modifiedBy":"ONEDATA","dateModified":"2017-05-17","deletedIndicator":"No"},{"value":"Positive","valueDescription":"Positive Contrast Agent","ValueMeaning":{"publicId":"2717685","version":"1","preferredName":"Positive Contrast Agent","longName":"2717685","preferredDefinition":"Contrast media that has a higher amplification and intensity than the surrounding tissue making the contrast look more opaque when seen in an x-ray.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Contrast Agent","conceptCode":"C71959","definition":"Contrast media that has a higher amplification and intensity than the surrounding tissue making the contrast look more opaque when seen in an x-ray.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"428B61E4-2D04-1694-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-12-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4FBA87A7-5348-3649-E053-F662850A6B71","beginDate":"2008-02-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-05-17","modifiedBy":"ONEDATA","dateModified":"2017-05-17","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2233241","version":"1","preferredName":"Medical Imaging","preferredDefinition":"Events, people, materials and activities uniquely defined by medical imaging.  ","longName":"MEDICAL IMAGING","context":"CIP","contextVersion":"2.31","origin":"DICOM:Digital Imaging and Communications in Medicine","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F96173D7-A9B4-3CBB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-12","modifiedBy":"SBREXT","dateModified":"2006-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2717682","version":"1","preferredName":"Oral Route of Administration Contrast Agent Type","preferredDefinition":"The introduction of a substance to the mouth or into the gastrointestinal tract by the way of the mouth, usually for systemic action. It is the most common, convenient, and usually the safest and least expensive route of drug administration, but it uses the most complicated pathway to the tissues and bioavailability varies. The disadvantages of method are hepatic first pass metabolism and enzymatic degradation of the drug within the gastrointestinal tract. This prohibits oral administration of certain classes of drugs especially peptides and proteins.:Substances used in radiography that allow visualization of certain tissues.:Type; a subdivision of a particular kind of thing.","longName":"C38288:C390:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oral Route of Administration","conceptCode":"C38288","definition":"The introduction of a substance to the mouth or into the gastrointestinal tract by the way of the mouth, usually for systemic action. It is the most common, convenient, and usually the safest and least expensive route of drug administration, but it uses the most complicated pathway to the tissues and bioavailability varies. The disadvantages of method are hepatic first pass metabolism and enzymatic degradation of the drug within the gastrointestinal tract. This prohibits oral administration of certain classes of drugs especially peptides and proteins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Contrast Agent","conceptCode":"C390","definition":"Substances administered during imaging procedures that allows delineation of internal structures. Contrast agents appear opaque due to the difference in absorption of X-rays or other electromagnetic waves and surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"428B61C1-2FE4-15B5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-12-30","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-12-30","modifiedBy":"ONEDATA","dateModified":"2007-12-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4FBA87A7-52E5-3649-E053-F662850A6B71","latestVersionIndicator":"Yes","beginDate":"2007-10-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-05-17","modifiedBy":"KNABLEJ","dateModified":"2017-07-07","changeDescription":"7/7/17 jk transferred context and added registration status per Round 5 finalization task.  5/17/17 tt, VD versioned to 1.1. Changed coded PVs to text, min/max length, definition, Context, registration status and added to NCI Standards CSI per Rnd 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2972035","version":"1","longName":"VCU FLT 8029","context":"NCIP"},{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2879403","version":"1","longName":"Virginia Commonwealth University","context":"NCIP"}]},{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3793463","version":"1","longName":"CT Imaging Agent CRF","context":"NCIP"}]},{"publicId":"3314439","version":"1","longName":"Imaging Modality","context":"ECOG-ACRIN","ClassificationSchemeItems":[{"publicId":"3314449","version":"1","longName":"Positron Emission Tomography (PET)","context":"ECOG-ACRIN"},{"publicId":"3314457","version":"1","longName":"PET Imaging Agent ","context":"ECOG-ACRIN"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"5635307","version":"1","longName":"CT Imaging Agent","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"If oral contrast was used, sp","type":"Preferred Question Text","description":"If oral contrast was used, specify type","url":null,"context":"NCI Standards"},{"name":"CRF Text","type":"Alternate Question Text","description":"Oral contrast type","url":null,"context":"NCIP"}],"origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"527E9C9C-181B-6850-E053-F662850AEAE3","latestVersionIndicator":"Yes","beginDate":"2008-01-31","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2017-06-21","modifiedBy":"KNABLEJ","dateModified":"2018-06-27","changeDescription":"6/27/18 jk upd to remove reference to \"draft new\" CDE as part of R5 upds.  6/21/17 Upd with new DEC; VD change to text values, transferred context, updated definition, WF/reg status and released per Round 5 finalization task. 11/18/13 removed caBIG ACRIN PET CSI; Associated with ACRIN PET CSI. jc  8/28/13 revised definition to clarify use of coded VD. Values did not change. jc 7/3/13 added alt question. jc 7/1/13 associated with CT Imaging Agent CRF CSI. jc  12/28/09 released for VCU FLT 8029 study.  2/12/08 - updated VD values with CUI terms.  1/31/08 - created in support of ACRIN PET data element.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}